| abstract |
The present invention relates to (hetero)arylcyclopropylamine compounds, in particular compounds of formula (I) as described and defined herein, and their use in therapy, including, for example, in the treatment or prevention of cancer, neurological diseases or disorders , or use in viral infections. Thus, in a particular aspect the invention relates to compounds of formula (II), formula (III), formula (IV), formula (V), formula (VI), formula (VII), formula (VIII), formula (IX). |